Aveo Pharmaceuticals Inc AVEO:NASDAQ

Last Price$4.15NASDAQ Previous Close - Last Trade as of 4:00PM ET 5/18/22

Today's Change-0.10(2.35%)
Bid (Size)$2.60 (1)
Ask (Size)$4.17 (33)
Day Low / High$4.03 - 4.24
Volume171.5 K
 

View Pharmaceuticals: Major IndustryPeer Comparison as of 05/18/2022

 

Aveo Pharmaceuticals Inc ( NASDAQ )

Price: $4.15
Change: -0.10 (2.35%)
Volume: 171.5 K
4:00PM ET 5/18/2022
 
 

Actinium Pharmaceuticals Inc ( NYSE MKT LLC )

Price: $6.03
Change: -0.17 (2.74%)
Volume: 132.2 K
8:00PM ET 5/18/2022
 
 

Matinas BioPharma Holdings Inc ( NYSE MKT LLC )

Price: $0.65
Change: -0.02 (2.71%)
Volume: 245.1 K
8:00PM ET 5/18/2022
 
 

Gamida Cell Ltd ( NASDAQ )

Price: $2.26
Change: -0.15 (6.22%)
Volume: 231.6 K
4:00PM ET 5/18/2022
 
 

PDS Biotechnology Corp ( NASDAQ )

Price: $4.98
Change: -0.37 (6.92%)
Volume: 288.1 K
4:00PM ET 5/18/2022
 

Read more news Recent News

-- Earnings Flash (AVEO) AVEO PHARMACEUTICALS Reports Q1 Revenue $20.9M, vs. Street Est of $20.8M
7:01AM ET 5/05/2022 MT Newswires

...

--JonesTrading Initiates AVEO Pharmaceuticals With Buy Rating, $12 Price Target
2:25PM ET 3/14/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

AVEO Pharmaceuticals Net Loss Narrows, Revenue Increases in Q4
7:28AM ET 3/14/2022 MT Newswires

AVEO Pharmaceuticals (AVEO) reported a Q4 net loss Monday of $0.21 per share, compared with a loss of $0.44 a year earlier. Analysts polled by Capital IQ...

-- Earnings Flash (AVEO) AVEO PHARMACEUTICALS Posts Q4 Revenue $17.6M, vs. Street Est of $18.3M
7:03AM ET 3/14/2022 MT Newswires

...

Company Profile

Business DescriptionAVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. View company web site for more details
Address30 Winter Street
Boston, Massachusetts 02108
Phone+1.617.400.0101
Number of Employees17
Recent SEC Filing05/13/20223/A
President, Chief Executive Officer & DirectorMichael P. Bailey
Chief Operating OfficerJebediah Ledell
Chief Financial OfficerErick J. Lucera
Vice President-Information TechnologyMatthew Coulter

Company Highlights

Price Open$4.15
Previous Close$4.15
52 Week Range$3.06 - 7.59
Market Capitalization$143.1 M
Shares Outstanding34.5 M
SectorHealth Technology
IndustryPharmaceuticals: Major
Next Earnings Announcement08/04/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.26
Beta vs. S&P 500N/A
Revenue$5.4 M
Net Profit Margin-67.57%
Return on Equity-85.29%

Analyst Ratings as of 03/14/2022

Buy
4
Overweight
1
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset